Table 3.
Variables | p-EGFR expression | EGFR overexpression | COX-2 overexpression | ||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Negative | Positive | P valuea | Negative | Positive | P valuea | Negative | Positive | P valuea | |
EGFR overexpression | |||||||||
Negative | 31 | 9 | 0.087 | ||||||
Positive | 21 | 16 | |||||||
COX-2 overexpression | |||||||||
Negative | 26 | 6 | 0.047 | 19 | 13 | 0.356 | |||
Positive | 26 | 19 | 21 | 24 | |||||
Ki-67 | |||||||||
< median value | 22 | 17 | 0.497 | 30 | 9 | 0.092 | 22 | 17 | 0.011 |
≥ median value | 18 | 20 | 22 | 16 | 10 | 28 | |||
Microvessel density | |||||||||
< median value | 20 | 17 | 0.821 | 24 | 13 | 0.808 | 13 | 24 | 0.356 |
≥ median value | 20 | 20 | 28 | 12 | 19 | 21 |